NCT00961558

Brief Summary

A varicocele is the presence of dilated testicular veins in the scrotum. Although it is generally agreed that a varicocele is the most common identifiable pathology in infertile men (detected in up to 40% of men in some series of men with infertility), the influence of a varicocele on male fertility potential and role of varicocelectomy in restoring of fertility remain the subject of ongoing controversy. The present controversy on the effect of varicocelectomy on male fertility potential has led many clinicians to dismiss the diagnosis of a varicocele altogether and instead, offer alternative treatments to the couple. Many of these alternative therapies are expensive and risky for the patients and their children. Several recent reviews have critically examined the results of randomized, controlled trials of varicocelectomy on fertility potential. The effect of varicocelectomy on spontaneous pregnancy rates remains controversial. The investigators hypothesize that a varicocelectomy will result in a significant improvement in fertility and testicular function in infertile men with a clinical varicocele.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
300

participants targeted

Target at P75+ for not_applicable

Geographic Reach
1 country

4 active sites

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 17, 2009

Completed
2 days until next milestone

First Posted

Study publicly available on registry

August 19, 2009

Completed
Last Updated

May 28, 2012

Status Verified

August 1, 2011

First QC Date

August 17, 2009

Last Update Submit

May 24, 2012

Conditions

Keywords

varicocelectomymale infertilityclinical varicocelesrandomized control trial

Outcome Measures

Primary Outcomes (1)

  • Pregnancy rates in infertile couples 6 months after surgery or observation alone

    7 months after randomization

Secondary Outcomes (1)

  • Mean improvements in sperm parameters, serum testosterone levels 6 months after surgery or observation alone; complication rate after varicocelectomy; mean time (days) off work after varicocelectomy.

    7 months after randomization

Study Arms (2)

Observation arm

NO INTERVENTION

Patient will not to undergo any form of Assisted Reproductive Technologies for a period of 6 months

Surgery Arm

OTHER

Patients will have varicocelectomy within 1 month of assessment and will not undergo any form of Assisted Reproductive Technologies for a period of 6 months after surgery

Procedure: Varicocelectomy

Interventions

Varicocelectomy

Also known as: Microsurgical inguinal varicocelectomy, Sub-inguinal varicocelectomy
Surgery Arm

Eligibility Criteria

Age20 Years - 65 Years
Sexmale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Minimum of one year of infertility
  • Clinically detectable grade 2 or grade 3 varicocele
  • A minimum of 2 abnormal semen analyses (defined as \< 20 million sperm/ml, and/or \< 30% progressive motility and/or normal sperm morphology \< 14% by Kruger Strict Morphology (WHO) within 6 months of entry into the study)
  • Female partner \< 38 years of age

You may not qualify if:

  • Other medically correctable cause of infertility (e.g., prolactinoma, infection, exposure to marijuana)
  • Severe oligospermia on 2 sperm analyses (defined as \< 5 million sperm/ml)
  • Severe asthenospermia on 2 sperm analyses (\< 5% progressive motility)
  • Prior varicocele repair
  • Solitary testicle
  • Significant female-factor infertility (tubal factor or anovulation only)
  • Inability or unwillingness to comply with study protocol (including failure to submit 2 post-intervention semen samples)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

Queen Elizabeth II Health Sciences Centre

Halifax, Nova Scotia, B3H 2A7, Canada

Location

Mount Sinai Hospital

Toronto, Ontario, M5G 1X5, Canada

Location

McGill University Health Centre; Royal Victoria Hospital

Montreal, Quebec, H3A 1A1, Canada

Location

McGill University; St. Mary Hospital Centre

Montreal, Quebec, H3T 1M5, Canada

Location

MeSH Terms

Conditions

Infertility, MaleVaricocele

Condition Hierarchy (Ancestors)

Genital Diseases, MaleGenital DiseasesUrogenital DiseasesInfertilityMale Urogenital DiseasesVascular DiseasesCardiovascular Diseases

Study Officials

  • Keith A Jarvi, MD

    MOUNT SINAI HOSPITAL

    STUDY CHAIR
  • Armand S Zini, MD

    McGill University

    STUDY DIRECTOR
  • Kirk C Lo, MD

    MOUNT SINAI HOSPITAL

    PRINCIPAL INVESTIGATOR
  • Ethan D Grober, MD

    MOUNT SINAI HOSPITAL

    PRINCIPAL INVESTIGATOR
  • Peter T Chan, MD

    McGill University

    PRINCIPAL INVESTIGATOR
  • John E Grantmyre, MD

    Dalhousie University

    PRINCIPAL INVESTIGATOR
  • Edward G Hughes, MD

    McMaster University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

August 17, 2009

First Posted

August 19, 2009

Last Updated

May 28, 2012

Record last verified: 2011-08

Locations